Although the knowledge of APS pathogenesis has grown in recent years, the management
principles and strategies are largely unchanged. There is an unmet need for evaluating …

Antiphospholipid syndrome: an update for clinicians and scie... : Current Opinion in
Rheumatology Antiphospholipid syndrome: an update for clinicians and scientists : Current …

Antiphospholipid syndrome (APS) is a hypercoagulable state characterized by arterial and
venous thromboses and pregnancy morbidity in the presence of antiphospholipid …

Warfarin, heparin, and/or antiplatelet drugs are the standard of care for aPL-positive
patients. Recent studies suggest novel approaches that target new coagulation and …

Antiphospholipid syndrome is an autoimmune systemic disorder characterized by arterial,
venous, or small vessel thrombosis and/or recurrent early pregnancy loss, fetal loss, or …

Abstract Purpose of Review This review focuses on new clinical aspects of antiphospholipid
syndrome (APS) in the last 5 years. Recent Findings The pathogenesis of APS is related to …

Background Antiphospholipid syndrome (APS) or 'Hughes syndrome'is a prothrombotic
disease characterized by thrombosis and pregnancy morbidity in the presence of …

Antiphospholipid antibodies (aPL) are a family of autoantibodies directed against
phospholipid-binding plasma proteins, most commonly β2-glycoprotein-I. Primary …

Current therapeutic recommendations for thrombosis prevention in patients with
antiphospholipid syndrome (APS) are limited to anticoagulation with vitamin K antagonists …

Antiphospholipid syndrome is an autoimmune disease characterized by thrombosis and
pregnancy morbidity occurring in patients persistently positive for aPL. Current therapeutic …